![](/img/cover-not-exists.png)
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
Bazzola, L, Foroni, C, Andreis, D, Zanoni, V, R Cappelletti, M, Allevi, G, Aguggini, S, Strina, C, Milani, M, Venturini, S, Ferrozzi, F, Giardini, R, Bertoni, R, Turley, H, Gatter, K, Petronini, P G,Volume:
112
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2014.563
Date:
January, 2015
File:
PDF, 894 KB
english, 2015